Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | AKT1 | P31749 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20576145 | 1.00 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL9124694 | 1.00 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL8656303 | 0.91 | L3MBTL1 (0.41) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL18359864 | 0.89 | ALDH1A1 (0.48) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL8472422 | 0.89 | ALDH1A1 (0.48) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL8472423 | 0.89 | ALDH1A1 (0.48) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL6513912 | 0.89 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL11018000 | 0.88 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL7276228 | 0.88 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL9807251 | 0.88 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12625431-B2 | EUV resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4222158-A1 | N4-HYDROXYCYTIDINE DERIVATIVES AND USE THEREOF AS ANTIVIRAL AGENT | Ascletics Bioscience Co., Ltd. (CN) | 2023-08-09 | — | — | EP | disclosed |
| WO-2023111683-A1 | N4-HYDROXYCYTIDINE DERIVATIVES AND USE THEREOF AS ANTIVIRAL AGENT | ASCLETIS BIOSCIENCE CO., LTD. (CN) | 2023-06-22 | — | — | WO | disclosed |
| US-20230098881-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-03-30 | — | — | US | disclosed |
| EP-4013499-A1 | COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN | GILEAD SCIENCES, INC. (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021030438-A1 | COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN | GILEAD SCIENCES, INC. (US) | 2021-02-18 | — | — | WO | disclosed |
| EP-3197880-B1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES WITH ANTI-INFLAMMATORY AND ANTI-THROMBOTIC EFFECT | Bayer Pharma AG (DE) | 2018-10-24 | — | — | EP | disclosed |
| EP-2678349-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2014-01-01 | — | — | EP | disclosed |
| WO-2012115256-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-30 | — | — | WO | disclosed |
| US-7649015-B2 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | GILEAD SCIENCES, INC. (US) | 2010-01-19 | — | — | US | disclosed |
| US-20050209197-A1 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | GILEAD SCIENCES, INC. | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209197-A1 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | PPA1, PPME1, PNP | L3MBTL1 807/4885ALDH1A1 3361/4885LMNA 2684/4885 |
| US-12625431-B2 | EUV resist underlayer film-forming composition | EEF1A1, ARF1, EMG1 | L3MBTL1 1093/4885ALDH1A1 2046/4885LMNA 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.